ArticleJournal of clinical medicine2023

Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort.

Alica Kubesch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.